Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

JANX

Janux Therapeutics Inc

May 08 • 04:00PM ET

14.18

-0.36 -2.51 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS ALLO IOVA KYMR NRIX

| Held by: XBI VTI IWM VXF IBB IWN SCHA VTWO IWO VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.84	Insider Own	8.62%	Shs Outstand	60.87M	Perf Week	-1.15%
Market Cap	864.45M	Forward P/E	-	EPS next Y	-2.80	Insider Trans	-0.49%	Shs Float	55.59M	Perf Month	-2.44%
Enterprise Value	-70.37M	PEG	-	EPS next Q	-0.32	Inst Own	100.57%	Short Float	13.38%	Perf Quarter	8.45%
Income	-114.48M	P/S	62.96	EPS this Y	-4.95%	Inst Trans	-8.08%	Short Ratio	7.25	Perf Half Y	-48.53%
Sales	13.73M	P/B	0.92	EPS next Y	-45.99%	ROA	-11.01%	Short Interest	7.44M	Perf YTD	2.72%
Book/sh	15.47	P/C	0.90	EPS next 5Y	-23.99%	ROE	-11.72%	52W High	35.34 -59.89%	Perf Year	-46.25%
Cash/sh	15.68	P/FCF	-	EPS past 3/5Y	-6.44% -62.26%	ROIC	-11.92%	52W Low	12.12 16.96%	Perf 3Y	3.39%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.11% -	Gross Margin	85.59%	Volatility	4.02% 4.11%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-5.13	EPS Y/Y TTM	-35.51%	Oper. Margin	-1143.11%	ATR (14)	0.60	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.01	Sales Y/Y TTM	47.10%	Profit Margin	-833.60%	RSI (14)	43.39	Recom	1.58
Dividend Gr. 3/5Y	- -	Current Ratio	17.01	EPS Q/Q	-2.21%	SMA20	-4.78%	Beta	2.57	Target Price	40.35
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	-1.32%	Rel Volume	0.84	Prev Close	14.54
Employees	109	LT Debt/Eq	0.02	Earnings	May 07 AMC	SMA200	-27.17%	Avg Volume	1.03M	Price	14.18
IPO	Jun 11, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.17% -14.06%	Trades		Volume	865,870	Change	-2.51%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)